{{Rsnum
|rsid=11894252
|Gene=EPAS1
|Chromosome=2
|position=46306237
|Orientation=plus
|GMAF=0.4376
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=EPAS1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 39.3 | 50.0 | 10.7
| HCB | 0.7 | 22.6 | 76.6
| JPT | 0.9 | 25.7 | 73.5
| YRI | 9.5 | 44.2 | 46.3
| ASW | 10.5 | 59.6 | 29.8
| CHB | 0.7 | 22.6 | 76.6
| CHD | 2.8 | 26.6 | 70.6
| GIH | 22.8 | 42.6 | 34.7
| LWK | 17.3 | 50.0 | 32.7
| MEX | 29.3 | 51.7 | 19.0
| MKK | 15.4 | 54.5 | 30.1
| TSI | 40.2 | 51.0 | 8.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21131975
|Title=Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
|OA=1
}}

{{PMID Auto
|PMID=22113997
|Title=The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}